Hepatocellular Carcinoma (HCC)
3 competing products in clinical development for Hepatocellular Carcinoma (HCC).
Pipeline by Phase
Phase 12
Phase 31
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib + Sorafenib | Eisai | Phase 3 | Completed | 40 |
| ERY974 + Tocilicumab + Atezolizumab + Bevacizumab | Chugai Pharmaceutical | Phase 1 | Active | 33 |
| CT-01 + EVEROLIMUS | Captor Therapeutics | Phase 1 | Recruiting | 26 |